Literature DB >> 28104416

Longitudinal Cohort Study on the Incidence of Primary Open-Angle Glaucoma in Bai Chinese.

Chen-Wei Pan1, Wen-Yan Yang2, Dan-Ning Hu3, Jian-Gang Xu4, Zhi-Qiang Niu2, Yuan-Sheng Yuan2, Min-Bin Yu4, Hua Zhong5.   

Abstract

PURPOSE: The prevalence of primary open-angle glaucoma (POAG) in China has been reported previously, and was lower than that in white and black populations. However, the incidence of POAG in China has not been reported. Therefore, a longitudinal study was conducted to determine the 5-year cumulative incidence and predictors of POAG in China.
DESIGN: Population-based cohort study.
METHODS: A total of 1520 participants (71.3% of the subjects in the baseline survey) of Bai ethnicity were examined and followed for 5 years. Glaucoma was defined based on the International Society of Geographical and Epidemiological Ophthalmology Classification criteria. Multivariable logistic regression models were fitted to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULTS: A total of 19 new cases of POAG were detected. The 5-year cumulative incidence of POAG was 1.3% (95% CI, 0.7-1.9). In multivariate analyses, incident POAG was associated with baseline variables including increased age (OR, 4.3; 95% CI, 1.4-13.8; P = .02; 70 years or older vs 50-59 years), elevated IOP (OR, 3.5; 95% CI, 2.0-5.9; P < .001; per 10 mm Hg increase), lower education level (OR, 0.3; 95% CI, 0.1-0.8; P = .02; post-primary education vs no formal education), and the presence of myopia (OR, 3.4; 95% CI, 1.3-8.6; P < .01).
CONCLUSIONS: The average annual incidence of POAG in Bai Chinese was lower than that in populations of African descent and white race. The results are important to elucidate the racial/ethnic difference in POAG incidence and for the clinical management and health resource allocation in China.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28104416     DOI: 10.1016/j.ajo.2017.01.008

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

Review 1.  [Assessment of risk factors for the occurrence of open angle glaucoma : Guidelines of the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 2.  Risk factors for open-angle glaucoma and recommendations for glaucoma screening.

Authors:  Alexander K Schuster; Felix M Wagner; Norbert Pfeiffer; Esther M Hoffmann
Journal:  Ophthalmologe       Date:  2021-04-21       Impact factor: 1.059

3.  Agreement of Optic Nerve Head Evaluation of Primary Open-Angle Glaucoma Between General Ophthalmologists and Glaucoma Specialists.

Authors:  Xiangmei Kong; Ying Huang; Wenqing Zhu; Mingshui Fu; Xi Shen; Fang Wang; Xinghuai Sun
Journal:  Risk Manag Healthc Policy       Date:  2021-05-06

Review 4.  Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis.

Authors:  Shiming Wang; Yue Liu; Guangying Zheng
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

5.  Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients.

Authors:  Jong Joo Moon; Yong Woo Kim; Baek-Lok Oh; Kyungdo Han; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Ki Ho Park; Hajeong Lee; Yong Chul Kim; Jin Wook Jeoung
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

6.  Differential metabolic markers associated with primary open-angle glaucoma and cataract in human aqueous humor.

Authors:  Chen-Wei Pan; Chaofu Ke; Qin Chen; Yi-Jin Tao; Xu Zha; Yuan-Ping Zhang; Hua Zhong
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

Review 7.  Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis.

Authors:  Kelsey V Stuart; Kian Madjedi; Robert N Luben; Sharon Y L Chua; Alasdair N Warwick; Mark Chia; Louis R Pasquale; Janey L Wiggs; Jae H Kang; Pirro G Hysi; Jessica H Tran; Paul J Foster; Anthony P Khawaja
Journal:  Ophthalmology       Date:  2022-01-31       Impact factor: 14.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.